Thermal Energy in the Treatment of Cervicogenic Dizziness

June 21, 2022 updated by: Roseli Saraiva Moreira Bittar, University of Sao Paulo General Hospital

Thermal Energy of Helical® Adhesive Pads in the Treatment of Cervicogenic Dizziness

Cervical pain contributes to postural deviations and imbalance. Nanotechnology may be used for the treatment of neck pain by fixing to the skin small rounds silicone patches containing double spiral carbon nanotubes arranged in the form of a coil (Helical), which would then relieve dizziness caused by muscular contraction.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The selected patients should have neck pain arising from muscle contraction with loss of balance or instability lasting more than 90 days and normal electrooculography. Treatment consisted of placing 10 Helical patches, placebo or active, distributed as follows: two in the upper cervical area, two in the lower cervical area (near the 5th and 6th vertebrae), two in the upper trapezius muscle area (between neck and shoulder), and four in the tender point area (as reported by the patient). Using a Visual Analogue Scale (VAS) and specific questionnaires, the investigators will match pain, muscle tension and dizziness scores from Day 1 to those from Day 15 and Day 30.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • São Paulo, Brazil, 05403-010
        • University of Sao Paulo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Cervicogenic Dizziness diagnosis
  • Normal otoneurological examination
  • Signed the informed consent form
  • Neck without other radiological changes, which are not solely attributable to aging (osteophytosis, rectification, disc space reduction).

Exclusion Criteria:

  • Active vestibular disease
  • Traumatic neck injury
  • Neurological
  • Rheumatic or orthopedic diseases not attributable to aging (fractures, tumors) and/or that have surgical indication
  • Somatoform diseases; cognitive limitations.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Active

The treatment consisted of placing 10 active Helical patches spread as follows:

  • Two in the upper cervical area (suboccipital);
  • Two in the lower cervical area (near the 5th and 6th vertebrae);
  • Two in the upper trapezius muscle area (between neck and shoulder);
  • Four in the tender point area (as reported by the patient).
Active Helical® patches and non-active patches (placebo) are placed at cervical tension points
Other Names:
  • Non-active patches
Placebo Comparator: Placebo

The treatment consisted of placing 10 placebo Helical patches spread as follows:

  • Two in the upper cervical area (suboccipital);
  • Two in the lower cervical area (near the 5th and 6th vertebrae);
  • Two in the upper trapezius muscle area (between neck and shoulder);
  • Four in the tender point area (as reported by the patient).
Active Helical® patches and non-active patches (placebo) are placed at cervical tension points
Other Names:
  • Non-active patches

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvement of dizziness
Time Frame: 60 days
Improvement of dizziness indices provided by the visual analogue scale. Technically speaking, Visual Analog for Dizziness consists of a horizontal (or vertical) line, usually 100mm in length. The left end of the line signifies no dizziness which is depicted by a smiling face while the right end signifies the worst possible dizziness with a frowning face.
60 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvement of cervical neck pain
Time Frame: 60 days

Improvement of cervical neck pain indices provided by the visual analogue scale.

Technically speaking, Visual Analog for Pain consists of a horizontal (or vertical) line, usually 100mm in length. The left end of the line signifies no pain which is depicted by a smiling face while the right end signifies the worst possible pain with a frowning face.

60 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 26, 2018

Primary Completion (Actual)

November 1, 2021

Study Completion (Actual)

May 1, 2022

Study Registration Dates

First Submitted

June 12, 2022

First Submitted That Met QC Criteria

June 16, 2022

First Posted (Actual)

June 22, 2022

Study Record Updates

Last Update Posted (Actual)

June 28, 2022

Last Update Submitted That Met QC Criteria

June 21, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dizziness

Clinical Trials on Helical® patches

Subscribe